Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS ClinicalTrials.gov record update

Efficacy of Alpha-blockers (Tamsulosin) in the Treatment of Symptomatic Dysuria in Multiple Sclerosis in Women

This page presents selected fields from the linked source record. It does not add a medical interpretation.

Open original source record ↗

Record identity and dates

Source
ClinicalTrials.gov
Source record ID
NCT05439902
Title field or adapter rule
protocolSection.identificationModule.officialTitle
Ingested At
2026-04-25T22:26:25.965548+00:00
Published At
2024-06-25T00:00:00+00:00
Record Updated At
2024-06-25
Timestamp Basis
source retrieval time was not retained by the feed adapter
Date limitation
source retrieval time was not retained by the feed adapter

Fields recorded by this source

protocolSection.conditionsModule.conditions
["Multiple Sclerosis", "Dysuria", "Lower Urinary Tract Symptoms", "Voiding Dysfunction", "Urinary Retention"]
protocolSection.statusModule.lastUpdatePostDateStruct.date
"2024-06-25"
protocolSection.identificationModule.nctId
"NCT05439902"
protocolSection.identificationModule.officialTitle
"Efficacy of Alpha-blockers (Tamsulosin) in the Treatment of Symptomatic Dysuria in Multiple Sclerosis in Women"
protocolSection.statusModule.overallStatus
"RECRUITING"
protocolSection.designModule.phases
["NA"]
protocolSection.statusModule.resultsFirstPostDateStruct.date
""

Study condition terms

  • Multiple Sclerosis (protocolSection.conditionsModule.conditions)
  • Dysuria (protocolSection.conditionsModule.conditions)
  • Lower Urinary Tract Symptoms (protocolSection.conditionsModule.conditions)
  • Voiding Dysfunction (protocolSection.conditionsModule.conditions)
  • Urinary Retention (protocolSection.conditionsModule.conditions)

Intervention details are not present in the imported fields for this record. No drug-condition relationship is inferred from co-listing.

This index keeps the source fields it imported; it may not contain the complete original record. Verify wording and context in the linked source.